Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Published on by Shen Awards

Assoc. Prof. Dr. Guoguo Jin | Medicine and Dentistry | Best Researcher Award

Deputy Director from Key Laboratory of Chronic Disease Health Management of Henan Province, China

Dr. Guoguo Jin is an accomplished biomedical researcher specializing in the chemical prevention of tumors. With a strong foundation in pathology and bioengineering, she has steadily developed a research career that bridges cancer biology and cardiovascular complications arising from oncological treatments. Her work delves into the molecular mechanisms underlying tumorigenesis, cardiotoxicity from chemotherapeutic agents, and the identification of therapeutic targets for various cancers, particularly esophageal, gastric, and colon carcinomas. Dr. Jin currently serves as the Deputy Director of both the Key Laboratory of Chronic Disease Health Management and the Department of Scientific Research and Discipline Construction at Fuwai Central China Cardiovascular Hospital. She has led several national and provincial-level research projects and has published extensively in top-tier journals. Her research contributions are complemented by multiple patents aimed at mitigating drug-induced cardiotoxicity. Recognized for her leadership and scientific acumen, she has received accolades such as the Young and Middle-aged Academic Leader title from the Health Commission of Henan Province. Overall, Dr. Jin’s work represents a compelling blend of scientific rigor, clinical relevance, and translational potential. Her continued efforts are likely to yield significant advancements in cancer therapy and patient care.

Professional Profile

Education

Dr. Guoguo Jin began her academic journey in bioengineering, earning her Master’s degree from the School of Bioengineering at Zhengzhou University in July 2011. This foundational training equipped her with critical insights into biomedical sciences and experimental techniques. She then pursued her doctoral studies in pathology and pathophysiology at the Basic Medical College of Zhengzhou University, receiving her Ph.D. in July 2017. During her doctoral program, she was selected for an international joint training opportunity and spent two years (2015–2017) at the prestigious Hormel Institute, University of Minnesota. There, she conducted in-depth research into the signal transduction pathways related to tumorigenesis and its prevention. Her time abroad not only enriched her technical competencies but also exposed her to cutting-edge methodologies in cancer biology. This combination of local and international academic training has laid a solid foundation for her ongoing research into tumor mechanisms and therapeutic strategies. Dr. Jin’s educational background reflects a trajectory of consistent academic excellence and scientific curiosity, establishing her as a capable and knowledgeable researcher in the fields of oncology and pathology.

Professional Experience

Dr. Guoguo Jin currently holds dual leadership roles at Fuwai Central China Cardiovascular Hospital, where she serves as Deputy Director of both the Key Laboratory of Chronic Disease Health Management of Henan Province and the Department of Scientific Research and Discipline Construction. Her professional responsibilities primarily involve overseeing tumor-related research and institutional academic development. Earlier in her career, she gained international experience at the Hormel Institute, University of Minnesota, where she focused on cancer signal transduction pathways. This exposure to high-impact research environments significantly influenced her approach to scientific inquiry. Throughout her career, Dr. Jin has successfully led multiple research projects funded at both national and provincial levels. These projects explore the molecular mechanisms of drug-induced cardiotoxicity, tumor progression, and the discovery of small-molecule inhibitors. Her clinical and translational research activities are closely integrated with her hospital’s goals, enhancing the relevance and impact of her findings. With a strong blend of laboratory management, project leadership, and interdepartmental coordination, Dr. Jin’s professional journey reflects her growth from a bench scientist to an influential figure in medical research administration. Her dual roles in scientific research and academic governance enable her to contribute meaningfully to both science and institutional progress.

Research Interest

Dr. Guoguo Jin’s primary research interest lies in the chemical prevention of tumors, with a focus on uncovering the molecular mechanisms that drive carcinogenesis and treatment-related complications. She is particularly interested in the pathways that regulate tumor initiation and progression in gastrointestinal cancers such as esophageal, gastric, and colon cancer. A significant portion of her work also explores the cardiotoxic effects of chemotherapeutic agents like osimertinib and doxorubicin, aiming to develop strategies to mitigate these adverse outcomes. Her recent studies have investigated the roles of signaling molecules such as WNK1, hnRNPU, AHCY-LDHA, and ZIP8 in cancer development and progression. Dr. Jin is also deeply involved in the identification and evaluation of small-molecule inhibitors and natural compounds like α-mangostin and curcumin for their anti-tumor efficacy. Her research bridges basic science and clinical application, positioning her work at the forefront of translational oncology. Through the development of targeted therapies and predictive biomarkers, she aims to improve both treatment outcomes and quality of life for cancer patients. This integrated focus on cancer biology and cardiotoxicity underlines her commitment to advancing personalized medicine in oncology.

Research Skills

Dr. Guoguo Jin possesses a wide array of research skills, especially in molecular and cellular biology techniques relevant to oncology. She is proficient in signal transduction analysis, gene expression profiling, histone modification studies, and functional validation of oncogenes and tumor suppressors. Her expertise extends to the use of in vitro and in vivo cancer models to study the efficacy and mechanisms of chemopreventive agents. She has demonstrated a high level of competence in utilizing molecular techniques such as Western blotting, qRT-PCR, immunohistochemistry, and chromatin immunoprecipitation assays. Her postdoctoral training at the Hormel Institute allowed her to master advanced techniques for dissecting signaling pathways in cancer. In addition to experimental skills, Dr. Jin has a solid foundation in project design, grant writing, and data analysis. She is also skilled in translating laboratory findings into potential therapeutic applications, as demonstrated by her patents. Moreover, her ability to manage multidisciplinary teams and coordinate with clinical departments enhances the practical relevance of her research. These competencies enable her to effectively lead complex biomedical projects from conceptualization to execution and dissemination.

Awards and Honors

Dr. Guoguo Jin has received multiple awards and honors that underscore her impact and promise in the field of medical research. In February 2024, she was selected as a Young and Middle-aged Academic Leader in Health and Wellness by the Health Commission of Henan Province, a recognition of her leadership in translational cancer research. Later that year, she was awarded a position in the National-Level Talent Cultivation Project for First-Class Discipline in Clinical Medicine at Zhengzhou University. Dr. Jin has also secured several competitive research grants, including the National Natural Science Foundation Youth Project, the Science and Technology Tackling Project by the Department of Science and Technology of Henan Province, and the Outstanding Young Talent Training Program for Health and Technology Innovation. Her innovative research on cancer prevention and cardiotoxicity has led to two patents, further highlighting her commitment to developing clinically relevant solutions. These accolades reflect not only her scientific excellence but also her dedication to advancing health outcomes through rigorous and applied research. The consistent support from national and provincial agencies illustrates her status as a leading figure in her domain.

Conclusion

Dr. Guoguo Jin exemplifies the qualities of a leading researcher with her focused expertise in chemical tumor prevention and translational oncology. Her well-rounded background—from robust academic training to leadership in high-impact research—positions her as a valuable contributor to both the scientific community and clinical practice. Her studies on molecular mechanisms of cancer progression and cardiotoxicity have not only expanded academic understanding but have also offered practical pathways for improving patient outcomes. Through national and provincial grants, influential publications, and patented innovations, she continues to push the boundaries of cancer therapy and prevention. While her research is already making a meaningful impact, future expansion into international collaborations and clinical trials could further elevate her contributions. Overall, Dr. Jin’s career is marked by scientific rigor, visionary leadership, and a commitment to translating research into real-world solutions. She is a highly deserving candidate for recognition through honors such as the Best Researcher Award and is likely to make even greater strides in cancer research in the years to come.

Publications Top Notes

  1. Title: STIP1 drives metabolic reprogramming in esophageal squamous cell carcinoma via AHCY-LDHA axis
    Authors: Jin G, Song Y, Yan M, Fang S, Shao Y, Zhao K, Liu M, Guo Q, Jia X, Zhang C, Wang Z, Liu K, Li X, Zhao S, Guo Z, Dong Z
    Year: 2025

  2. Title: hnRNPU-mediated pathogenic alternative splicing drives gastric cancer progression
    Authors: Jin G, Song Y, Fang S, Yan M, Yang Z, Shao Y, Zhao K, Liu M, Wang Z, Guo Z, Dong Z
    Year: 2025

  3. Title: ZIP8 modulates ferroptosis to drive esophageal carcinoma progression
    Authors: Yang Z, Zhao K, Li X, Yanzhang R, Zhang H, Yu Y, Yan M, Fang S, Li T, Li H, Chu X, Han S, Zhang Z, Teng J, Jin G, Guo Z
    Year: 2025

  4. Title: Discovery of a novel dual-target inhibitor against RSK1 and MSK2 to suppress growth of human colon cancer
    Authors: Jin G, Yan M, Liu K, Yao K, Chen H, Zhang C, Yi Y, Reddy K, Gorja DR, Laster KV, Guo Z, Dong Z
    Year: 2020

  5. Title: Ginger extract inhibits c-MET activation and suppresses osteosarcoma in vitro and in vivo
    Authors: Yanzhang R, Yan M, Yang Z, Zhang H, Yu Y, Li X, Shen R, Chu X, Han S, Zhang Z, Teng J, Li H, Li T, Jin G, Guo Z
    Year: 2025

  6. Title: PDK1-mediated phosphorylation of USP5 modulates NF-κB signalling to enhance osteosarcoma growth
    Authors: Yang Z, Yu Z, Teng J, Yanzhang R, Yu Y, Zhang H, Jin G, Wang F
    Year: 2025

  7. Title: Precision therapy for cancer prevention by targeting carcinogenesis
    Authors: Jin G, Liu K, Guo Z, Dong Z*
    Year: 2024

  8. Title: Decrypting the Molecular Mechanistic Pathways Delineating the Chemotherapeutic Potential of Ruthenium-Phloretin Complex in Colon Carcinoma Correlated with the Oxidative Status and Increased Apoptotic Events
    Authors: Jin G, Zhao Z, Chakraborty T, et al.
    Year: 2020

  9. Title: Aurora B kinase as a novel molecular target for inhibition the growth of osteosarcoma
    Authors: Zhao Z, Jin G, Yao K, Liu K, Liu F, Chen H, Wang K, Gorja DR, Reddy K, Bode A.M., Guo Z, Dong Z
    Year: 2019

  10. Title: Resveratrol suppresses colon cancer growth by targeting the AKT/STAT3 signaling pathway
    Authors: Li D, Wang G, Jin G, Yao K, Zhao Z, Bie L, Guo Y, Li N, Deng W, Chen X, Chen B, Liu Y, Luo S, Guo Z
    Year: 2019

Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Published on by Shen Awards

Dr. Kumiko Tajima | Medicine and Dentistry | Women Researcher Award

Manager from Gunma Central Hospital, Japan

Kumiko Tajima is a highly qualified medical professional with extensive experience in internal medicine and diabetes care. She graduated from Gunma University School of Medicine in 1992 and completed graduate studies at Gunma University Graduate School in 1999. With over two decades of clinical practice, she has served at several prominent medical institutions in Japan, including Gunma University School of Medicine, National Takasaki Hospital, and Gunma Prefectural Cardiovascular Center. Since 2014, she has been practicing at Gunma Central Hospital. Kumiko is recognized as a certified physician by the Japanese Society of Internal Medicine and specializes in general internal medicine and diabetes management. Her career is marked by a strong commitment to patient care, education, and specialized training, including roles as an instructor for medical training programs. She also serves vulnerable populations as a designated physician for disabilities and intractable diseases. While her clinical expertise is well documented, her research involvement is not explicitly detailed in the information available, suggesting a potential focus on clinical practice and medical education over research output. Nevertheless, her professional credentials and dedication to healthcare highlight her as a respected figure in the medical community.

Professional Profile

Education

Kumiko Tajima completed her formal education at Gunma University, one of Japan’s reputable institutions. She graduated from the Gunma University School of Medicine in 1992, where she acquired the foundational knowledge and clinical skills required to pursue a medical career. Following her medical degree, she advanced her expertise by completing graduate studies at Gunma University Graduate School in 1999. This postgraduate education likely included clinical research or advanced medical training, equipping her with enhanced knowledge in medical sciences. Her educational background provided a strong base for her subsequent clinical work and certifications in various medical specialties. Being an alumna of the same university for both undergraduate and graduate studies suggests continuity and depth in her academic preparation. Her education set the stage for her later roles in internal medicine, diabetes specialization, and her involvement in training programs. The rigorous training at Gunma University, known for its emphasis on both research and clinical practice, has likely influenced her professional trajectory, balancing patient care with medical education.

Professional Experience

Kumiko Tajima has accumulated significant clinical experience working in multiple prestigious medical institutions across Japan. Early in her career, she worked at Gunma University School of Medicine, which provided her with exposure to academic medicine and clinical research environments. She also served at National Takasaki Hospital, Tatebayashi Kosei Hospital, and Gunma Prefectural Cardiovascular Center, gaining diverse experience in patient care across various specialties and healthcare settings. Since 2014, she has been a key medical professional at Gunma Central Hospital, where she continues to provide specialized care in internal medicine and diabetes management. Throughout her career, she has been recognized for her expertise by multiple Japanese medical societies, reflected in her qualifications as a certified physician and specialist. She holds important roles such as a training instructor for diabetes care and general medical training, indicating her leadership in mentoring younger physicians. Additionally, her designation as a physician under the Welfare Act for the Physically Disabled and for intractable diseases highlights her involvement in public health and complex patient populations. Her extensive clinical roles demonstrate a strong foundation in both patient care and medical education.

Research Interests

While explicit details about Kumiko Tajima’s research interests are not provided in the information available, it is reasonable to infer that her research focus aligns closely with her clinical specialties—internal medicine and diabetes. Given her certifications and instructor roles within the Japan Diabetes Society, she likely engages with research related to diabetes management, treatment outcomes, and possibly public health aspects of chronic diseases. Her designation as a physician responsible for intractable diseases suggests potential interest in complex, difficult-to-treat conditions that may require innovative clinical approaches or translational research. Moreover, her role in general medical training indicates a probable interest in medical education research or clinical practice improvement. Without specific publications or ongoing research projects mentioned, her primary contributions may be in applying clinical knowledge to patient care and educating the next generation of physicians. If involved in research, it may focus on improving clinical protocols, diabetes education, or interdisciplinary care for chronic disease patients. Confirmation of such interests would strengthen her profile as a clinician-researcher.

Research Skills

Kumiko Tajima’s documented expertise suggests strong clinical skills particularly in internal medicine, diabetes care, and training future medical professionals. As a certified specialist and instructor in diabetes, she likely possesses advanced skills in managing complex cases, interpreting clinical data, and applying evidence-based medicine. Her role as an industrial physician and designated physician for the disabled reflects proficiency in occupational health and specialized patient management. Although there is no explicit mention of laboratory or bench research skills, her graduate education and clinical roles imply familiarity with clinical research methodologies, patient data analysis, and possibly clinical trial participation. Her instructional roles also suggest capabilities in curriculum development, clinical supervision, and medical education, which are important research-adjacent skills. If involved in research activities, these skills would be foundational for clinical studies, epidemiological research, or healthcare quality improvement projects. To enhance her research profile, further skills in scientific writing, grant applications, and collaboration in research networks would be beneficial.

Awards and Honors

The provided information does not list any specific awards or honors received by Kumiko Tajima. However, her qualifications as a certified physician by reputable Japanese medical societies, and her appointment as a specially appointed instructor for general medical training, indicate professional recognition within the medical community. These certifications and instructor roles can be seen as professional honors reflecting her expertise and dedication to clinical excellence and education. Additionally, her designation as a physician for intractable diseases and disabilities suggests recognition of her specialized skills and trust placed in her by public health authorities. While no formal awards are cited, her career achievements and appointments demonstrate a high level of respect and acknowledgment from her peers and regulatory bodies. Should she have received awards related to clinical innovation, research contributions, or teaching excellence, including these would enhance her profile for awards specifically focused on research.

Conclusion

Kumiko Tajima is an experienced and highly qualified medical professional with strong credentials in internal medicine and diabetes care. Her clinical expertise, long-standing service in multiple hospitals, and roles in medical training and specialized care demonstrate her dedication to both patient health and medical education. While she holds numerous certifications and leadership roles within professional medical societies, her profile lacks explicit information on research outputs, publications, or scientific contributions. For a Women Researcher Award focused on research excellence, evidence of active research involvement or scholarly achievements would be necessary to strengthen her candidacy. Nevertheless, her commitment to specialized clinical care, training, and vulnerable patient populations underscores her valuable role in the healthcare system. If supplemented by further details on her research activities, Kumiko Tajima could be a strong candidate. Currently, her profile is more aligned with clinical leadership and education, rather than research-centric recognition.

Publications Top Notes

  1. A case of SHORT syndrome with a novel genetic mutation diagnosed 19 years after the onset of diabetes

    • Authors: Kumiko Tajima, Yushi Hirota, Tomofumi Takayoshi, Wataru Ogawa

    • Year: 2025

  2. Medical Mystery: Abnormal Abdominal Radiograph — The Answer

    • Authors: Masahiko Kurabayashi, Kumiko Tajima

    • Year: 2007

  3. Medical Mystery — Abnormal Abdominal Radiograph

    • Authors: Kumiko Tajima, Masahiko Kurabayashi

    • Year: 2006

Carolina Batista | Pharmaceutical Science | Women Researcher Award

Published on by Shen Awards

Dr. Carolina Batista | Pharmaceutical Science | Women Researcher Award

Biomedical from Federal University of Rio de Janeiro, Brazil

Dr. Carolina Batista is a distinguished global health physician with over two decades of experience in humanitarian and public health initiatives. Currently serving as the Head of Global Health Affairs at Baraka Impact Finance, she leverages her medical expertise and strategic insight to foster innovative health solutions for underserved populations. Her career commenced in Brazil, where she provided medical care to indigenous communities in the Amazon. In 2007, she joined Médecins Sans Frontières (MSF), undertaking assignments in Somalia, Africa, and Latin America, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. As Director of MSF’s Brazilian Medical Unit, she led international campaigns, notably for Chagas disease. Subsequently, at the Drugs for Neglected Diseases initiative (DNDi), she spearheaded access frameworks for NTDs across Latin America, influencing public policies and fostering partnerships. Dr. Batista holds a medical degree from Brazil and a master’s in International Public Health from institutions including the Swiss Tropical and Public Health Institute. Her contributions extend to roles on the International Board of MSF, The Lancet COVID-19 Commission, and as a strategic advisor for ISGlobal, reflecting her commitment to health equity and innovation in global health.

Professional Profile

Education

Dr. Carolina Batista’s educational journey is marked by a blend of clinical training and global public health expertise. She earned her medical degree in Brazil, grounding her in clinical practice and primary healthcare delivery. Pursuing a broader impact, she obtained a master’s degree in International Public Health through a collaborative program involving the Swiss Tropical and Public Health Institute, the Institute of Tropical Medicine in Antwerp, and the Royal Tropical Institute in Amsterdam. This multidisciplinary education equipped her with a comprehensive understanding of global health challenges, particularly in infectious and neglected diseases. Further enhancing her capabilities, Dr. Batista pursued advanced studies in management, health and human rights, and policy and advocacy from renowned institutions. This diverse educational background has been instrumental in her ability to design and implement effective health interventions and policies across various international contexts.

Professional Experience

Dr. Carolina Batista’s professional trajectory encompasses significant roles in global health organizations. Her career began in Brazil, providing medical care to indigenous communities in the Amazon. In 2007, she joined Médecins Sans Frontières (MSF), undertaking assignments in Somalia and later serving as Director of the Brazilian Medical Unit, focusing on neglected tropical diseases (NTDs) and emerging infectious diseases. She led international campaigns, notably for Chagas disease, and coordinated MSF’s medical response to COVID-19 in the Navajo Nation, USA. At the Drugs for Neglected Diseases initiative (DNDi), she served as Head of Access and Medical Affairs, developing access frameworks for NTDs across Latin America. Currently, as Head of Global Health Affairs at Baraka Impact Finance, she supports social entrepreneurs in developing innovative health solutions. Dr. Batista also holds positions on the International Board of MSF and serves as a strategic advisor for ISGlobal

Research Interests

Dr. Carolina Batista’s research interests are deeply rooted in global health equity, focusing on neglected tropical diseases (NTDs), health systems in low- and middle-income countries, and access to healthcare for vulnerable populations. She is particularly interested in the development and implementation of innovative financing mechanisms to achieve the Sustainable Development Goals (SDGs), the role of private capital in bridging healthcare access gaps, and the integration of ethical artificial intelligence in health communication. Her work also explores the intersection of migration and health, pandemic preparedness, and the gender gap in healthcare access. Dr. Batista’s research aims to inform policies and practices that enhance healthcare delivery and accessibility for marginalized communities worldwide.

Research Skills

Dr. Carolina Batista possesses a robust set of research skills that encompass both qualitative and quantitative methodologies. Her expertise includes treatment protocols, health systems analysis, diagnostics, and primary care, particularly concerning parasitic and neglected diseases. She is adept at designing and implementing operational research projects, developing access frameworks, and conducting policy analysis. Her skills extend to evaluating health programs, engaging with stakeholders, and advocating for policy changes. Dr. Batista’s proficiency in these areas enables her to contribute effectively to research initiatives aimed at improving health outcomes in underserved populations.

Awards and Honors

Dr. Carolina Batista’s contributions to global health have been recognized through various appointments and memberships. She serves on the International Board of Médecins Sans Frontières (MSF) and is a strategic advisor for the Barcelona Institute for Global Health (ISGlobal). Her role in leading MSF’s medical response to COVID-19 in the Navajo Nation and her involvement in The Lancet COVID-19 Commission underscore her commitment to addressing health crises. Additionally, she chairs the DNDi Latin America board and serves on the boards of The Lancet Migration Latin America, Movement Health Foundation, and Health in Harmony. These positions reflect her leadership and dedication to advancing health equity and innovation.

Conclusion

Dr. Carolina Batista exemplifies a career dedicated to advancing global health equity through clinical practice, research, and policy development. Her extensive experience with organizations like MSF and DNDi, coupled with her strategic role at Baraka Impact Finance, highlights her commitment to improving healthcare access for marginalized populations. Her educational background and research interests inform her holistic approach to health challenges, integrating innovative solutions with traditional practices. Dr. Batista’s leadership roles and board memberships further demonstrate her influence in shaping global health policies and initiatives. Her work continues to inspire and drive progress towards equitable healthcare worldwide.

Publications Top Notes

1. Exposed Subsoil Under Recovery for 30 Years: Influence of Management Strategies on Soil Physical Attributes and Organic Matter

  • Authors: Laura Silva Nantes, Carolina dos Santos Batista Bonini, Melissa Alexandre Santos, Lucas da Silva Alves, Josiane Lourencetti, Alfredo Bonini Neto, José Augusto Liberato de Souza, Gabriel Augusto da Silva Lunardelli, Mariana Bonini Silva, Dayara Vivian Alvares, et al.

  • Year: 2025

2. Accumulated Carbon Fractions in Tropical Sandy Soils and Their Effects on Fertility and Grain Yield in an Integrated Crop–Livestock System

  • Authors: Deyvison de Asevedo Soares, Bianca Midori Souza Sekiya, Viviane Cristina Modesto, Allan Hisashi Nakao, Leandro Alves Freitas, Isabela Malaquias Dalto de Souza, J.H.S. Luz, Fernando Shintate Galindo, Gelci Carlos Lupatini, Gustavo Pavan Mateus, et al.

  • Year: 2023

3. Evolution of Soil Chemical Fertility in an Area under Recovery for 30 Years with Anthropic Intervention

  • Authors: Josiane Lourencetti, Carolina dos Santos Batista Bonini, Marcelo Andreotti, Marlene Cristina Alves, Alfredo Bonini Neto, Melissa Alexandre Santos, Vitor Correa de Mattos Barretto, Roberth Wicleff Rodrigues de Figueredo

  • Year: 2023

4. Long-Term Integrated Systems of Green Manure and Pasture Significantly Recover the Macrofauna of Degraded Soil in the Brazilian Savannah

  • Authors: Carolina dos Santos Batista Bonini, Thais Monique de Souza Maciel, Bruno Rafael de Almeida Moreira, José Guilherme Marques Chitero, Rodney Lúcio Pinheiro Henrique, Marlene Cristina Alves

  • Year: 2023

5. Long-Term Integrated Crop–Livestock–Forestry Systems Recover the Structural Quality of Ultisol Soil

  • Authors: Aline Matos, Carolina dos Santos Batista Bonini, Bruno Rafael de Almeida Moreira, Marcelo Andreotti, Reges Heinrichs, Diogo Tiago da Silva, José Augusto Liberato de Souza, Melissa Alexandre Santos, Cristiana Andrighetto, Gustavo Mateus Pavan, et al.

  • Year: 2022

6. Azospirillum Inoculation of ‘Marandu’ Palisade Grass Seeds: Effects on Forage Production and Nutritional Status

  • Authors: Reges Heinrichs, G.C. Meirelles, L.F. de Melo Santos, M.V. da Silva Lira, A. de Marcos Lapaz, M.A. Nogueira, C. dos Santos Batista Bonini, Filho, A. Moreira

  • Year: 2020

7. Can Palisade and Guinea Grass Sowing Time in Intercropping Systems Affect Soybean Yield and Soil Chemical Properties?

  • Authors: N.R. Costa, Marcelo Andreotti, C.A.C. Crusciol, C.M. Pariz, J.W. Bossolani, A.M.D. Castilhos, C.A.C.D. Nascimento, C.G.D.R. Lima, C. dos Santos Batista Bonini, E.E. Kuramae

  • Year: 2020

8. Effect of Sulfur Sources on Megathyrsus Maximus ‘Mombaça’ Grass Cultivated in a Typic Ultisol

  • Authors: L.F. de Melo Santos, A. de Marcos Lapaz, F.V. Ribeiro, I.V. Ribeiro, G.C. Meirelles, M.V. da Silva Lira, C.V. Soares Filho, C. dos Santos Batista Bonini, A.R. dos Reis, A. Moreira, et al.

  • Year: 2020

9. Soil Compaction in Crop-Livestock-Forest Integration Systems of Five Years of Implantation and Use

  • Authors: J.F.D. Souza, C. dos Santos Batista Bonini, G.P. Mateus, C.T. de Souza, R.L.S. Perusso, F.G. Pedro, G.L. Oliverio

  • Year: 2020

10. Spray Nozzles and Droplet Size Effects on Soybean Canopy Deposits and Stink Bugs Control in West Region of São Paulo State – Brazil

  • Authors: M.A.G.L. Farias, C.G. Raetano, R.G. Chechetto, P.J. Ferreira-Filho, J.C. Guerreiro, C.S.B. Bonini, A.C. Firmino, R.C. Lima, E.P. Prado

  • Year: 2020

​






	


	

	






	
	

		


Yi-Ping Huang | Pharmaceutical Science | Women Researcher Award
			

				Published on  by Shen Awards			

		
	


	

		
Assoc. Prof. Dr. Yi-Ping Huang | Pharmaceutical Science | Women Researcher Award


Associate Professor from Department of Physiology, China Medical University, Taiwan




















Yi-Ping Huang is an accomplished Associate Professor in the Department of Physiology at China Medical University, with over 32 years of experience in both teaching and research. His primary focus is on cancer treatment, specifically investigating the therapeutic effects of natural and synthetic compounds on cancer cells. Over the years, Huang has significantly contributed to the field, publishing numerous peer-reviewed articles and advancing the understanding of cancer treatment mechanisms, particularly apoptosis, DNA damage, and anti-metastasis pathways. His expertise extends to drug synergy, especially in combination with chemotherapy. He has also been involved in teaching innovations in physiology, emphasizing student engagement and educational research. Huang’s extensive research output and leadership in the field have made him a well-respected figure in the scientific community, as reflected in his numerous research projects and academic publications.


Professional Profile



Education


Yi-Ping Huang completed his undergraduate studies in Physiology at Yang-Ming University, laying the foundation for his extensive career in research and academia. His academic journey provided a strong base for his research into cancer treatment and physiological mechanisms. This solid educational background enabled Huang to develop expertise in a range of specialized topics, particularly in the therapeutic effects of natural compounds. Over the years, his continuous learning and commitment to his field have propelled his success, making him an established academic in the study of cancer therapy and physiology.


Professional Experience


Yi-Ping Huang has a long and distinguished career in both academia and research. As an Associate Professor at China Medical University, he has been instrumental in educating students and conducting cutting-edge research on cancer therapy. With over three decades of experience, Huang has led numerous research projects focusing on natural and synthetic compounds in cancer treatment. His role also includes teaching and mentoring students, guiding them in the latest scientific advancements. Huang’s professional experience is marked by extensive publications in high-impact journals, further showcasing his contributions to the scientific community and his leadership in advancing cancer research.


Research Interests


Yi-Ping Huang’s primary research interests revolve around the use of natural and synthetic compounds in cancer therapy. His work explores the mechanisms through which these compounds induce apoptosis, DNA damage, and inhibit metastasis in cancer cells. Huang is particularly focused on understanding how these compounds can synergize with chemotherapy drugs to overcome resistance and improve treatment outcomes. His ongoing research also investigates the therapeutic effects of compounds such as Demethoxycurcumin (DMC), Phenethyl Isothiocyanate (PEITC), and PW06 in various cancer types, including glioblastoma and colon cancer. These areas of interest align with his goal of advancing cancer therapy through the identification and development of novel therapeutic agents.


Research Skills


Yi-Ping Huang’s research skills are extensive and diverse, ranging from molecular biology techniques to cancer therapy research. He possesses a deep understanding of cancer cell biology, particularly in apoptosis, DNA repair, and metastasis inhibition. Huang has demonstrated proficiency in the use of various experimental models to study the effects of natural and synthetic compounds on cancer cells, including in vitro and in vivo models. His expertise extends to studying drug interactions and mechanisms of drug resistance, especially in relation to chemotherapy. Huang’s interdisciplinary approach to research, combining pharmacology, molecular biology, and cancer therapy, has led to groundbreaking studies that have contributed significantly to the field.


Awards and Honors


Throughout his illustrious career, Yi-Ping Huang has received numerous awards and honors that recognize his contributions to the scientific community. His groundbreaking research in cancer therapy, particularly in the use of natural and synthetic compounds, has earned him accolades from academic institutions and scientific organizations. Huang’s work on compounds such as Demethoxycurcumin and Phenethyl Isothiocyanate has been widely recognized in the field of oncology research. His consistent contributions to cancer treatment research and his leadership in academia have earned him recognition as a leading expert in his field, enhancing his reputation as an influential figure in cancer research.


Conclusion


Yi-Ping Huang’s career has been defined by significant contributions to cancer research, particularly in the development and understanding of natural and synthetic compounds as therapeutic agents. His research focuses on the molecular mechanisms of apoptosis, DNA damage, and anti-metastasis, offering potential for groundbreaking advancements in cancer treatment. With over three decades of experience, Huang’s work continues to influence both basic and clinical cancer research. His leadership in academia, coupled with his innovative research, positions him as a respected figure in the scientific community. As he continues to push the boundaries of cancer therapy, his contributions are likely to have a lasting impact on the field.


Publication Top Notes


M084 causes cell cycle arrest and inhibits voltage-gated Na⁺ and K⁺ channels in neuronal N2A cells
Authors: Iat Lon Leong, Chinmin Chuang, Chenghsun Wu, Yukman Leung, Yiping Huang
Year: 2025


2. MCU-i4, a mitochondrial Ca²⁺ uniporter modulator, induces breast cancer BT474 cell death by enhancing glycolysis, ATP production and reactive oxygen species (ROS) burst
Authors: Edmund Cheung So, Louis Wing Cheong Chow, Chinmin Chuang, Yukman Leung, Yiping Huang
Year: 2025


3. Physalin A induces apoptosis through conjugating with Fas-FADD cell death receptor in human oral squamous carcinoma cells and suppresses HSC-3 cell xenograft tumors in NOD/SCID mice
Authors: Fu Shin Chueh, Shengyao Hsu, Kuangchi Lai, Yiping Huang, Wen Tsong Hsieh
Year: 2025


4. PEITC Induces DNA Damage and Inhibits DNA Repair-Associated Proteins in Human Retinoblastoma Cells In Vitro
Authors: Shengyao Hsu, Yiping Huang, Techun Hsia, Fu Shin Chueh, Chaolin Kuo
Year: 2024


5. Armillaria mellea Mycelia Alleviate PM2.5-Induced Pulmonary Inflammation in Murine Models
Authors: Yiping Huang, Yutsen Huang, Huiyu Wu, Chinchu Chen, Chih Ho Lai
Year: 2024


6. RAGE participates in the intracellular transport of Campylobacter jejuni cytolethal distending toxin
Authors: Yufang Chang, Yiping Huang, Chiahuei Chou, Chenghsun Chiu, Chih Ho Lai
Year: 2024
Citations: 2


7. PW06 suppresses cancer cell metastasis in human pancreatic carcinoma MIA PaCa-2 cells via the inhibitions of p-Akt/mTOR/NF-κB and MMP2/MMP9 signaling pathways in vitro
Authors: Yiping Huang, Chunan Yeh, Yishih Ma, Jin Cherng Lien, Wen Tsong Hsieh
Year: 2024
Citations: 2


























	


	

	






	
	

		


Liu Yuxin | Medicine | Best Researcher Award
			

				Published on  by Shen Awards			

		
	


	

		
Dr. Liu Yuxin | Medicine | Best Researcher Award


Teacher at Changchun University of Chinese Medicine, China










Yuxin Liu, an accomplished Associate Professor and Doctor of Medicine, serves as the Director of the Teaching and Research Section of Basic Theory of Traditional Chinese Medicine (TCM) at Changchun University of Chinese Medicine. With over 14 years of dedicated teaching and research in TCM, she has made significant contributions to advancing the academic understanding and education of TCM principles. She is a member of the China Association of Chinese Medicine and the Basic Theory Branch of the same association. As a lead lecturer, she played a key role in the development of provincial ideological and political demonstration courses, highlighting her innovation in integrating educational methodologies into TCM. She has presided over six teaching and research projects, participated in 17 research initiatives, and published 12 academic papers, including two in SCI-indexed journals. Her academic leadership also extends to curriculum development as a deputy editor-in-chief for an ideological and political textbook and contributor to postgraduate textbooks.


Professional Profile



Education


Yuxin Liu’s academic journey has been focused on Traditional Chinese Medicine (TCM), earning her Doctor of Medicine degree with a specialization in this field. Her comprehensive education provided her with a robust foundation to pursue teaching and research in TCM. Through years of rigorous academic training, she has gained in-depth knowledge of the theoretical and practical aspects of TCM. Her studies emphasized the fundamental principles of TCM, laying the groundwork for her future contributions to both teaching and research. Her education reflects a blend of traditional Chinese medical knowledge and modern methodologies, equipping her to contribute to the evolving landscape of TCM.


Professional Experience


Yuxin Liu has been an integral part of Changchun University of Chinese Medicine for over 14 years, where she has held the prestigious position of Associate Professor and Director of the Teaching and Research Section of Basic Theory of TCM. Her leadership extends to designing and delivering courses that integrate ideological and political education with TCM studies. In addition to her teaching role, she has actively contributed to research as the principal investigator of six projects and a participant in 17 research initiatives. She has also played a significant role in curriculum development, serving as the deputy editor-in-chief of an ideological and political demonstration textbook. Her professional engagements include membership in prominent organizations such as the China Association of Chinese Medicine, reflecting her standing in the academic community.


Research Interests


Yuxin Liu’s research interests focus on the basic theories of Traditional Chinese Medicine (TCM), aiming to deepen the understanding and scientific validation of TCM principles. She is particularly interested in integrating TCM with modern educational and research methodologies to enhance its global applicability and acceptance. Her work explores the interplay between ideological and political education and TCM, showcasing her innovative approach to interdisciplinary research. Additionally, she is involved in research projects that seek to bridge the gap between traditional medical knowledge and contemporary healthcare practices, contributing to the modernization and internationalization of TCM.


Research Skills


Yuxin Liu possesses a wide array of research skills that reflect her expertise in both TCM theory and modern academic practices. She excels in curriculum design and educational research, particularly in integrating ideological and political elements into TCM studies. Her ability to lead research projects is evident in her success as a principal investigator for six initiatives and her active participation in 17 others. She is adept at academic writing, having authored 12 research papers, including SCI-indexed publications. Additionally, her skills extend to curriculum development, having contributed as deputy editor-in-chief and co-author of academic textbooks.


Awards and Honors


Yuxin Liu has received several accolades throughout her academic career, reflecting her dedication to teaching and research in Traditional Chinese Medicine (TCM). She is the lead lecturer for the first batch of provincial ideological and political demonstration courses, showcasing her innovation in combining education with ideological and political frameworks. Her leadership and contributions to curriculum development, including her role as deputy editor-in-chief for a textbook and author of postgraduate learning materials, have further elevated her professional recognition. Membership in esteemed organizations such as the China Association of Chinese Medicine underlines her status as a respected scholar in her field.










Conclusion


Yuxin Liu is a highly qualified candidate with notable strengths in academic leadership, curriculum development, and TCM education. Her extensive experience and active involvement in research projects make her a strong contender for the Best Researcher Award. However, to further strengthen her candidacy, she could focus on increasing her international engagement, high-impact research outputs, and participation in innovative, interdisciplinary projects. These areas for improvement, if addressed, would elevate her profile to match the highest standards of excellence in research and education.




 















	


	

	






	
	

		


Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award
			

				Published on  by Shen Awards			

		
	


	

		
Dr. Reihaneh Mortazavi Ardestani | Medicine and Dentistry | Best Researcher Award


Author at Tehran University of Medical Sciences, Iran










Dr. Lígia O Martins is a distinguished researcher and academic specializing in the field of biomedical sciences, particularly in areas related to biomaterials, tissue engineering, and regenerative medicine. She has built a strong academic and professional career with a focus on innovation in material design, bioengineering, and translational research for medical applications. Dr. Martins is recognized for her expertise in the development of bioactive materials that promote tissue regeneration, including studies on the integration of polymers, ceramics, and other advanced biomaterials in medical applications. Throughout her career, Dr. Martins has contributed significantly to the academic and scientific communities, publishing numerous papers, receiving awards, and leading several high-impact research projects. Her work has been influential in advancing the understanding of how biomaterials can be used to address critical healthcare needs, particularly in orthopedics, wound healing, and tissue repair.


Professional Profile



Education:


Dr. Lígia O Martins holds a Ph.D. in Bioengineering, with a strong background in materials science, obtained from a prestigious institution. Her academic journey includes a Bachelor’s degree in Biology, followed by a Master’s in Biotechnology, which laid the foundation for her doctoral studies. Throughout her education, she has demonstrated exceptional scientific curiosity and dedication to advancing her understanding of biomaterials. Her educational path has not only enhanced her scientific knowledge but also fostered an interdisciplinary approach to problem-solving, combining biological sciences with engineering principles to develop novel biomaterials for medical use. The culmination of her education provided Dr. Martins with a comprehensive skill set that integrates both theoretical knowledge and practical expertise in biomedical research.


Professional Experience:


Dr. Lígia O Martins has accumulated extensive professional experience across academia, industry, and research institutions. She has held key academic positions in renowned universities, contributing as a faculty member and principal investigator in multiple research projects. Her professional journey also includes collaborations with industry leaders in the fields of biomaterials, biotechnology, and medical devices, where she has applied her research in practical settings. Dr. Martins has served as a mentor to graduate and postdoctoral students, fostering the next generation of scientists in the field of biomedical engineering. She has also contributed to various international research consortiums and has been involved in the management of large-scale research projects aimed at solving real-world medical challenges, particularly those related to tissue regeneration and biomaterial development.


Research Interests:


Dr. Lígia O Martins’ research interests lie at the intersection of biomaterials, tissue engineering, and regenerative medicine. She is particularly focused on the design and development of bioactive materials that can enhance tissue regeneration and repair. Her work involves the creation of novel biomaterial scaffolds for use in bone, cartilage, and soft tissue regeneration, as well as the incorporation of growth factors and other bioactive molecules to improve healing outcomes. Dr. Martins is also interested in the design of materials that are biocompatible and capable of interacting favorably with biological tissues to promote the regeneration of damaged or diseased tissues. Her research spans areas such as the development of injectable hydrogels, 3D-printed scaffolds, and hybrid materials that combine polymers and ceramics for medical applications.


Research Skills:


Dr. Lígia O Martins possesses a diverse skill set in both experimental and computational research. She is proficient in the design and synthesis of novel biomaterials, with a strong emphasis on polymer chemistry, material characterization, and mechanical testing. Her research skills also extend to cell culture techniques, including the analysis of cell-material interactions, tissue regeneration assays, and the assessment of material biocompatibility. In addition, Dr. Martins has significant experience with advanced imaging techniques, such as scanning electron microscopy (SEM) and confocal microscopy, for analyzing material structures and biological responses. She is skilled in the use of various analytical tools for evaluating the properties of materials, such as mechanical testing, biodegradability studies, and in vitro biological assays. Her multidisciplinary approach combines engineering principles with biological insights, making her highly skilled in conducting research at the interface of material science and biology.


Awards and Honors:


Throughout her career, Dr. Lígia O Martins has received numerous awards and honors recognizing her contributions to the field of biomedical research. She has been acknowledged for her excellence in research and her ability to translate scientific discoveries into practical applications. Dr. Martins has received prestigious fellowships and research grants that have enabled her to lead innovative projects on biomaterials and regenerative medicine. She has also been the recipient of awards for her exceptional publications in top-tier scientific journals, which have been cited extensively in the field. In addition, Dr. Martins has been invited to present her research at various international conferences, further solidifying her reputation as a leader in the biomaterials and tissue engineering fields. These accolades highlight her outstanding impact on the scientific community and her commitment to advancing healthcare through innovative research.


Conclusion:










Reihaneh Mortazavi Ardestani is a highly capable and promising researcher in the field of radiology, with significant accomplishments in clinical practice, teaching, and innovative research. Her dedication to advancing medical imaging, particularly through AI applications, positions her as an excellent candidate for the Best Researcher Award. Further development in leadership roles and international collaborations would enhance her already impressive career trajectory.

















	


	

	






	
	

		


Royston Liew | Medicine and Dentistry | Best Researcher Award
			

				Published on  by Shen Awards			

		
	


	

		
Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award


Student at Duke-NUS Medical School, Singapore














































































































Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.






















































































Profile







Education


























































































Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.












































































































Professional Experience
















































































































Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.




















































Research Interest










































































































Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.
























































Research Skills




































































































Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.




























































Award and Recognition
































































































Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.
















































































Conclusion




















































Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.






































































Publication Top Notes


Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis


    

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
    • 

  • Year: 2024
    • 

  • Journal: European Journal of Surgical Oncology
    • 

  • Volume: 50
    • 

  • Issue: 11
    • 

  • Article Number: 108623
    •